CIK 0000939767 · Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043257395
- Phone
- 6508377000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- 4 Open-market sale Director sold 7,712 shares at $48.45 ($373,646)
- 4 Open-market sale Director sold 20,634 shares at $46.00 ($949,164)
- 4 Open-market sale Director sold 60,000 shares at $45.71 ($2,742,600)
- 4 Gift President and CEO gave 109,676 shares (gift)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations · Other events
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- DEFA14A Proxy Proxy Materials
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Grant or award EVP, Research and Development acquired 52,018 shares (grant or award)
- 4 Grant or award EVP and CFO acquired 52,018 shares (grant or award)
- 4 Grant or award SVP and General Counsel acquired 23,119 shares (grant or award)
- 4 Grant or award EVP, Commercial acquired 40,459 shares (grant or award)
- 4 Grant or award President and CEO acquired 160,437 shares (grant or award)
- 4 Open-market sale EVP, Research and Development sold 47,918 shares at $44.50 ($2,132,351)
Page 3 of 126 · 2,517 filings